These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 27814453

  • 1. Fluctuation Analysis of Peak Expiratory Flow and Its Association with Treatment Failure in Asthma.
    Kaminsky DA, Wang LL, Bates JH, Thamrin C, Shade DM, Dixon AE, Wise RA, Peters S, Irvin CG.
    Am J Respir Crit Care Med; 2017 Apr 15; 195(8):993-999. PubMed ID: 27814453
    [Abstract] [Full Text] [Related]

  • 2. Management of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety.
    Lenney W, McKay AJ, Tudur Smith C, Williamson PR, James M, Price D, MASCOT Study Group.
    Health Technol Assess; 2013 Feb 15; 17(4):1-218. PubMed ID: 23380178
    [Abstract] [Full Text] [Related]

  • 3. Randomized comparison of strategies for reducing treatment in mild persistent asthma.
    American Lung Association Asthma Clinical Research CentersWake Forest University, Winston-Salem, NC, USA., Peters SP, Anthonisen N, Castro M, Holbrook JT, Irvin CG, Smith LJ, Wise RA.
    N Engl J Med; 2007 May 17; 356(20):2027-39. PubMed ID: 17507702
    [Abstract] [Full Text] [Related]

  • 4. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD, Nelson H, Borker R, Emmett A, Jhingran P, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2004 May 17; 22(12):815-25. PubMed ID: 15294013
    [Abstract] [Full Text] [Related]

  • 5. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
    van Noord JA, Schreurs AJ, Mol SJ, Mulder PG.
    Thorax; 1999 Mar 17; 54(3):207-12. PubMed ID: 10325895
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of salmeterol/fluticasone compared with montelukast alone (or add-on therapy to fluticasone) in the treatment of bronchial asthma in children and adolescents: a systematic review and meta-analysis.
    Zhou XJ, Qin Z, Lu J, Hong JG.
    Chin Med J (Engl); 2021 Nov 15; 134(24):2954-2961. PubMed ID: 34784306
    [Abstract] [Full Text] [Related]

  • 7. The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma.
    Ringdal N, Eliraz A, Pruzinec R, Weber HH, Mulder PG, Akveld M, Bateman ED, International Study Group.
    Respir Med; 2003 Mar 15; 97(3):234-41. PubMed ID: 12645830
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.
    Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ.
    Chest; 2001 Apr 15; 119(4):1021-6. PubMed ID: 11296164
    [Abstract] [Full Text] [Related]

  • 9. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA.
    Respir Med; 2000 Jun 15; 94(6):612-21. PubMed ID: 10921768
    [Abstract] [Full Text] [Related]

  • 10. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
    Chuchalin A, Jacques L, Frith L.
    Clin Drug Investig; 2008 Jun 15; 28(3):169-81. PubMed ID: 18266402
    [Abstract] [Full Text] [Related]

  • 11. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A, Jarvis B.
    Drugs; 2000 Nov 15; 60(5):1207-33. PubMed ID: 11129128
    [Abstract] [Full Text] [Related]

  • 12. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
    Aubier M, Pieters WR, Schlösser NJ, Steinmetz KO.
    Respir Med; 1999 Dec 15; 93(12):876-84. PubMed ID: 10653049
    [Abstract] [Full Text] [Related]

  • 13. Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma.
    Van den Berg NJ, Ossip MS, Hederos CA, Anttila H, Ribeiro BL, Davies PI.
    Pediatr Pulmonol; 2000 Aug 15; 30(2):97-105. PubMed ID: 10922131
    [Abstract] [Full Text] [Related]

  • 14. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
    Grosclaude M, Cerruti JL, Delannay B, Hérent M, Spilthooren F, Desfougères JL.
    Eur Ann Allergy Clin Immunol; 2003 Nov 15; 35(9):356-62. PubMed ID: 14716965
    [Abstract] [Full Text] [Related]

  • 15. Outcomes associated with initiation of different controller therapies in a Medicaid asthmatic population: a retrospective data analysis.
    Balkrishnan R, Nelsen LM, Kulkarni AS, Pleasants RA, Whitmire JT, Schechter MS.
    J Asthma; 2005 Feb 15; 42(1):35-40. PubMed ID: 15801326
    [Abstract] [Full Text] [Related]

  • 16. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
    O'Shea O, Stovold E, Cates CJ.
    Cochrane Database Syst Rev; 2021 Apr 14; 4(4):CD007694. PubMed ID: 33852162
    [Abstract] [Full Text] [Related]

  • 17. Influence of leukotriene pathway polymorphisms on clinical responses to montelukast in Japanese patients with asthma.
    Kotani H, Kishi R, Mouri A, Sashio T, Shindo J, Shiraki A, Hiramatsu T, Iwata S, Taniguchi H, Nishiyama O, Iwata M, Suzuki R, Gonda H, Niwa T, Kondo M, Hasegawa Y, Kume H, Noda Y.
    J Clin Pharm Ther; 2012 Feb 14; 37(1):112-6. PubMed ID: 21385196
    [Abstract] [Full Text] [Related]

  • 18. Salmeterol/fluticasone propionate versus fluticasone propionate plus montelukast: a cost-effective comparison for asthma.
    Pieters WR, Wilson KK, Smith HC, Tamminga JJ, Sondhi S.
    Treat Respir Med; 2005 Feb 14; 4(2):129-38. PubMed ID: 15813665
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.
    Sheth K, Borker R, Emmett A, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2002 Feb 14; 20(13):909-18. PubMed ID: 12381242
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug 14; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.